IP Library Granted Patent US 9,127,304
Granted Patent B2
US 9,127,304 · App. 12/823,988 · Granted Sep 8, 2015

Probe immobilization and signal amplification for polymer-based biosensor

Inventors: Fang Wei (Santa Monica, CA); Wei Liao (Santa Monica, CA)
Assignee: The Regents of the University of California
C12Q1/6804C12Q1/6825
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,127,304
App. No.
12/823,988
Granted
Sep 8, 2015
Kind
B2
Abstract

The present invention provides methods of making polymer-based biosensors and the biosensors made by said methods, wherein the biosensors comprise conducting polymers and negatively charged nanoparticles comprising a capture moiety. The present invention also provides methods of detecting analytes in a solution by contacting the solution with said polymer-based biosensors.

Claims (10)

1. A method of detecting an analyte in a solution, the method comprising the steps of: (a) contacting the solution with a polymer-based biosensor, wherein the biosensor comprises a conducting polymer and a negatively charged nanoparticle, wherein the conducting polymer comprises a poly(pyrrole) and the negatively charged nanoparticle comprises a DNA dendrimer comprising a capture moiety capable of binding to the analyte and configured for amperometric detection; (b) applying a voltage to the biosensor; (c) determining a current intensity generated on the biosensor; and (d) detecting the presence or absence of the analyte in the solution, wherein the current intensity generated on the biosensor is linearly dependent on the amount of the analyte in the solution.

2. The method of claim 1 , wherein the analyte is a protein.

3. The method of claim 2 , wherein the protein is present at a concentration of between about 100 fg/mL to about 2.5 μg/mL.

4. The method of claim 1 , wherein the analyte is a nucleic acid.

5. The method of claim 4 , wherein the nucleic acid is present at a concentration of between about 10 aM to about 10 pM.

6. The method of claim 1 , wherein the solution comprises a bodily fluid.

7. The method of claim 6 , wherein the bodily fluid is saliva.

8. The method of claim 1 , wherein the analyte is an oral cancer biomarker.

9. The method of claim 8 , wherein the oral cancer biomarker is selected from the group consisting of interleukin (IL)-8 protein, IL-1β protein, and IL-8 mRNA.

10. The method of claim 1 , wherein the capture moiety is selected from the group consisting of an oligonucleotide, polypeptide, antibody or functional fragment thereof, an avidin, a streptavidin, a biotin, an aptamer, a L-RNA aptamer, a glutathione, an S-peptide, and an anti-biotin antibody.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2010
From: LIAO, WEI; WEI, FANG
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 024937/0801 →
CONFIRMATORY LICENSE Recorded Jul 22, 2010
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024726/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2010
From: LIAO, WEI; WEI, FANG
To: THE REGENT OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 024667/0927 →
Continuity (2)
Provisional Application 61220490 · Jun 25, 2009
Related Publication 20100330706A1 · Dec 30, 2010